Alice Giacobino

909 total citations
10 papers, 358 citations indexed

About

Alice Giacobino is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Alice Giacobino has authored 10 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Alice Giacobino's work include Pancreatic and Hepatic Oncology Research (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Alice Giacobino is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Alice Giacobino collaborates with scholars based in Italy, Malaysia and United Kingdom. Alice Giacobino's co-authors include Libero Ciuffreda, Anna Novarino, Graziella Bellone, Barbara Vizio, Giuseppe Montrucchio, Massimo Alessio, Francesco Novelli, Weidong Zhou, Paola Salacone and Mirella Giovarelli and has published in prestigious journals such as Journal of Proteome Research, Cancer Science and Journal of Cancer Research and Clinical Oncology.

In The Last Decade

Alice Giacobino

10 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alice Giacobino Italy 10 242 111 89 81 51 10 358
Woo Young Sun South Korea 9 162 0.7× 82 0.7× 64 0.7× 127 1.6× 64 1.3× 23 358
Angel Qin United States 12 343 1.4× 178 1.6× 94 1.1× 122 1.5× 45 0.9× 33 561
Haruhito Sakata Japan 13 154 0.6× 251 2.3× 62 0.7× 83 1.0× 81 1.6× 34 483
Francesca Sparano Italy 9 219 0.9× 113 1.0× 78 0.9× 65 0.8× 41 0.8× 19 369
Bangbo Zhao China 14 147 0.6× 205 1.8× 30 0.3× 127 1.6× 90 1.8× 43 435
David Rageot France 10 135 0.6× 66 0.6× 108 1.2× 65 0.8× 102 2.0× 18 398
Cristina Migali Italy 12 376 1.6× 91 0.8× 198 2.2× 66 0.8× 44 0.9× 17 511
Daniele Pozzessere Italy 14 230 1.0× 114 1.0× 103 1.2× 60 0.7× 43 0.8× 24 426
Nicholas P. Schaub United States 8 222 0.9× 66 0.6× 142 1.6× 33 0.4× 67 1.3× 8 403
Ettie Piura Israel 9 181 0.7× 202 1.8× 46 0.5× 61 0.8× 51 1.0× 13 383

Countries citing papers authored by Alice Giacobino

Since Specialization
Citations

This map shows the geographic impact of Alice Giacobino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Giacobino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Giacobino more than expected).

Fields of papers citing papers by Alice Giacobino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Giacobino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Giacobino. The network helps show where Alice Giacobino may publish in the future.

Co-authorship network of co-authors of Alice Giacobino

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Giacobino. A scholar is included among the top collaborators of Alice Giacobino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Giacobino. Alice Giacobino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Garrone, Ornella, Filippo Montemurro, Chiara Saggia, et al.. (2016). Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial—a multicenter retrospective study of eribulin in real life. SpringerPlus. 5(1). 59–59. 29 indexed citations
2.
Giacobino, Alice, et al.. (2015). Reference range for thyrotropin. Nuklearmedizin - NuclearMedicine. 54(3). 112–117. 21 indexed citations
3.
Novarino, Anna, Maria Antonietta Satolli, Isabella Chiappino, et al.. (2012). FOLFOX-4 Regimen or Single-agent Gemcitabine as First-line Chemotherapy in Advanced Biliary Tract Cancer. American Journal of Clinical Oncology. 36(5). 466–471. 11 indexed citations
4.
Vizio, Barbara, Anna Novarino, Alice Giacobino, et al.. (2012). Potential plasticity of T regulatory cells in pancreatic carcinoma in relation to disease progression and outcome. Experimental and Therapeutic Medicine. 4(1). 70–78. 46 indexed citations
6.
Santini, Daniele, Gaia Schiavon, Bruno Vincenzi, et al.. (2010). Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC). Current Cancer Drug Targets. 11(1). 123–129. 40 indexed citations
7.
Cappello, Paola, Michela Capello, Claudia Fredolini, et al.. (2010). Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer. Journal of Proteome Research. 10(1). 105–112. 106 indexed citations
8.
Novarino, Anna, Maria Antonietta Satolli, Isabella Chiappino, et al.. (2009). Oxaliplatin, 5-Fluorouracil, and Leucovorin as Second-Line Treatment for Advanced Pancreatic Cancer. American Journal of Clinical Oncology. 32(1). 44–48. 28 indexed citations
9.
Chiappella, Annalisa, et al.. (2009). Procalcitonin as a predictive marker of infections in chemoinduced neutropenia. Journal of Cancer Research and Clinical Oncology. 136(4). 611–615. 17 indexed citations
10.
Carbone, Anna, Barbara Vizio, Anna Novarino, et al.. (2009). IL-18 Paradox in Pancreatic Carcinoma: Elevated Serum Levels of Free IL-18 are Correlated With Poor Survival. Journal of Immunotherapy. 32(9). 920–931. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026